Clinical-Microbiomics A/S

CVR 37230634 · Public limited company (A/S) · Active · Low risk

Clinical-Microbiomics A/S is a Public limited company (A/S), founded on , based in København Ø. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 10 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 85.4m and a net result of DKK -2.6m.

Bankruptcy risk for Clinical-Microbiomics A/S

0.1%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 38% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
Current ratio50%–100% · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Reporting classReporting class C, mellemstor virksomhed · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
37230634
Status
Active
Company type
Public limited company (A/S)
Founded
(11 years)
Address
Fruebjergvej 3
2100 København Ø
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 2.1m
Employees
18 (2018)
Auditor
Beierholm Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 10
Missing annual reportNo
Negative equityNo
Equity ratio92.9%
Current ratio75%
Moves (last 2 years)0
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address611
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 2.8mDKK 548k
Net profitDKK -2.6mDKK -4.3m
EquityDKK 85.4mDKK 88.0m
Total assetsDKK 92.0mDKK 91.7m
CashDKK 1.9m–
Short-term debtDKK 6.1m–
Avg. employees37–

Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · Beierholm.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025177
1 Jan 2024 – 31 Dec 2024178
1 Jan 2023 – 31 Dec 2023180
1 Jan 2022 – 31 Dec 2022155
1 Jan 2021 – 31 Dec 2021109
1 Jan 2020 – 31 Dec 2020109
1 Jan 2019 – 31 Dec 2019164
1 Jan 2018 – 31 Dec 2018130
1 Jan 2017 – 31 Dec 2017106
2 Nov 2015 – 31 Dec 2016143

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEORasmus Vendler Toft-Kehler
CEOMorten Otto Alexander Sommer
BoardIsabelle Valerie de CremouxCurrent
BoardCaroline PopperCurrent
BoardMorten Otto Alexander SommerCurrent
BoardManoj Nirmal DadlaniCurrent
BoardNathan Allen LedeboerCurrent
BoardBruce Harvey GrantCurrent
BoardRasmus Vendler Toft-Kehler
BoardDennis Landbo Nielsen
BoardOle Skov
BoardMorten Otto Alexander Sommer
BoardHenrik Dalbøge
BoardMorten Otto Alexander Sommer
BoardMorten Asser Karsdal
BoardOle Skov
BoardThomas Alsbjerg
BoardTorben Thomasen
Owner (5%)MANJIN ApSCurrent
Owner (5%)VENDLER ApSCurrent
Owner (33%)Applied Industries Holding ABCurrent
Owner (5%)Health For Life Capital II Prima S.C.A. RAIFCurrent
Owner (5%)Health For Life Capital II FPCI – Alpha CompartmentCurrent
Owner (25%)MANJIN ApS
Owner (25%)VENDLER ApS
Owner (15%)Pinnacle Holding ApS
Owner (20%)OD Clinical Holding ApS
Owner (15%)Clinical-Microbiomics A/S
Owner (20%)MANJIN ApS
Owner (20%)VENDLER ApS
Owner (10%)Clinical-Microbiomics A/S
Owner (33%)OD Clinical Holding ApS
Owner (5%)TLC HOLDING ApS
Owner (15%)ADSIDIUS ApS
Owner (15%)DACCO INVEST ApS
Owner (10%)DACCO INVEST ApS
Owner (5%)TAL Invest ApS
Owner (5%)DACCO INVEST ApS
Owner (10%)TAL Invest ApS
Owner (10%)Verde Family Holding ApS
Owner (10%)MANJIN ApS
Owner (5%)TLC HOLDING ApS
Owner (10%)ADSIDIUS ApS
Owner (5%)DACCO INVEST ApS
Owner (10%)VENDLER ApS
Owner (5%)TAL Invest ApS
Owner (5%)Verde Family Holding ApS
Owner (5%)Health For Life Capital II Prima S.C.A. RAIF
Owner (5%)Health for Life Capital II FPCI - ALPHA Compartment
Owner (5%)REINHOLDT ENGINEERING ApS
Owner (5%)BIRKEHEGNET 13 HOLDING ApS
Owner (5%)ADSIDIUS ApS
AuditorBeierholm Godkendt RevisionspartnerselskabCurrent
AuditorDatoselskabet af den 3. juli 2016 RVT P/S
FounderMANJIN ApSCurrent
FounderVENDLER ApSCurrent

The CEOs' other companies

Rasmus Vendler Toft-Kehler – 5 other companies

Morten Otto Alexander Sommer – 11 other companies, of which 1 bankrupt

Address history (2 moves)

Fruebjergvej 3, 2100 København Ø
Ole Maaløes Vej 3, 2200 København N
Kogle Alle 5, 2970 Hørsholm

Former names

Clinical-Microbiomics A/S – now
Clinical-Microbiomics ApS –

Employees per year

Number of employees at Clinical-Microbiomics A/S per year9182016: 820162017: 1520172018: 182018

Other companies at the same address

Similar companies in København

Questions and answers about Clinical-Microbiomics A/S

Has Clinical-Microbiomics A/S gone bankrupt?

No, Clinical-Microbiomics A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Clinical-Microbiomics A/S?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the auditor of Clinical-Microbiomics A/S?

Clinical-Microbiomics A/S most recently used Beierholm Godkendt Revisionspartnerselskab.

When was Clinical-Microbiomics A/S founded?

Clinical-Microbiomics A/S was founded on 2 November 2015.

What is the equity of Clinical-Microbiomics A/S?

Equity was DKK 85.4m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.